XXXXXXXXX XXXXXXXX XXXXXX (XX) 2019/1977
ze xxx 26. xxxxxxxxx 2019
x xxxxxxxx xxxxxxxxxxxxxxxxx, benzyl(methyl)sulfidu, 2-xxxxxxxxxxxxxx, xxxxxx-2-xxxxx, 12-xxxxxxxxxxxxxxxxx, 2,5-xxxxxxxxxxxxxx, xxxx-2(xxxxx),4(xxxxx)-xxxxxxx x 2-xxxxx-4-xxxxxxx-5-xxxxxx-3(2X)-xxxxxxxx xxxx doplňkových xxxxx xxx kočky x xxx
(Xxxx x xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x xxxxxxx xx Xxxxxxx o xxxxxxxxx Xxxxxxxx xxxx,
x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx a Xxxx (XX) č. 1831/2003 xx xxx 22. xxxx 2003 o xxxxxxxxxxx xxxxxxx používaných xx xxxxxx xxxxxx (1), x xxxxxxx xx xx. 9 odst. 2 xxxxxxxxx xxxxxxxx,
xxxxxxxx x xxxxx xxxxxxx:
(1) |
Xxxxxxxx (XX) č. 1831/2003 xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx používaných xx xxxxxx zvířat a xxxxxx a postupy, xx jejichž xxxxxxx xx povolení xxxxxxx. Xxxxxx 10 xxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxxxxx xxxxxxxxxxx látek povolených xxxxx xxxxxxxx Xxxx 70/524/XXX (2). |
(2) |
Xxxxxxxxxxxxxxxx, xxxxxx(xxxxxx)xxxxxx, 2-xxxxxxxxxxxxx, xxxxxx-2-xxxx, 12-xxxxxxxxxxxxxxxx, 2,5-xxxxxxxxxxxxx, xxxx-2(xxxxx),4(xxxxx)-xxxxxx x 2-xxxxx-4-xxxxxxx-5-xxxxxx-3(2X)-xxxxxxx (xxxx jen „xxxxxxx xxxxx“) byly xxx xxxxxxxx xxxxxxx xxxxxxxx xxxx doplňkové xxxxx xxx xxxxxx pro xxxxx x xxx x xxxxxxx xx xxxxxxxx 70/524/EHS. Xxxxxxx xxxxxxxxx látky byly x xxxxxxx x xx. 10 xxxx. 1 xxxxxxxx (XX) x. 1831/2003 následně xxxxxxx do Xxxxxxxx xxx xxxxxxxxx xxxxx xxxx stávající xxxxxxxx. |
(3) |
V xxxxxxx s čl. 10 xxxx. 2 xxxxxxxx (XX) x. 1831/2003 ve xxxxxxx x xxxxxxx 7 xxxxxxxxx xxxxxxxx byla xxxxxx žádost x xxxxxxxxxxxx xxxxxxxxx látek xxx xxxxx x xxx x požadavkem xx xxxxxxxx xxxxxxxxx xxxxxxxxxxx látek xx xxxxxxxxx xxxxxxxxxxx xxxxx „xxxxxxxxxx xxxxxxxxx látky“. Xxxx xxxxxx xxxx xxxxxx spolu x xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxx čl. 7 xxxx. 3 xxxxxxxx (XX) x. 1831/2003. |
(4) |
Xxxxxxxx xxxx xxx xxxxxxxxxx potravin (xxxx xxx „úřad“) xxxxxx xx xxxx stanovisku xx xxx 27. xxxxx 2019 (3) x xxxxxx, xx xx xxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx dotčené xxxxx xxxxxxxxxx xxxxxx xx xxxxxx zvířat ani xx životní xxxxxxxxx. Xxxxxx xxxxxx x xxxxxx, že xxxx xxxxxxxx rizika xxx xxxxxxxxx. Jak xx xxxxxxxxxx, xxxxxxxxxx žadatel xxx xxxxxx xxxx, x xxxxx byla xxxxxxxx rizika xxx xxxxxxxxx, bezpečnostní xxxx. Xxxxxx xxxxxxxxxx xxxxx xxxxxx x xxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxx. Xxxx xxxxx xxxxxx xxxxxx x závěru xxxxxxx xxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxx xxxxxxx xxx uživatele. V xxxxxxxxxxxxx xxxxx jsou xxxxxxx xxxxxxx tato xxxxxx – rizika xxx xxxxxxxx xxxx x očí xxxx xxxxxxxx x 2,5-xxxxxxxxxxxxxx, 12-xxxxxxxxxxxxxxxxx, xxxx-2(xxxxx),4(xxxxx)-xxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxx(xxxxxx)xxxxxxx, 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanonu a 2-xxxxxxxxxxxxxx. Xxxxxx expozice xxxxxxxxx xxxx bylo xxxxxxxx u 12-xxxxxxxxxxxxxxxx, xxxxxx(xxxxxx)xxxxxxx x 2-xxxxxxxxxxxxxx. Xxxxxxxx x chybějícím xxxxxx xxxxxx xxxx xxxxxx k xxxxxx xxxxxxx xxxxxx xxx xxxxxxxxx. Xxxxxx se xxxxx domnívá, že xx xxxx být xxxxxxx xxxxxx xxxxxxxx xxxxxxxx, xxx se xxxxxxxxx xxxxxxx xx xxxxxx zdraví, xxxxxxx xxxxx xxx o xxxxxxxxx xxxxxxxxx látky. Xxxxxxxxx xxxxx xxxxxx xxx xxxxxxx, xxxxx xxxxxx xxxxxx x xxxxxxxx potravin, byly xx xxxxxxx xxxxxxxx Xxxxxx (XX) x. 429/2008 (4) vyňaty z xxxxxxxxxx xxxxxxx posouzení xxxxx xx xxxxxxx xxxxxxxxx, neboť xxxxxx xxxxx xx xxxxxxx xxxxxxxxx není xxxxxxxx. Xxxxxxx x xxxxxxxx xxxxx nejsou xxxxxxx xx velkých xxxxxxxxx, x jejich vliv xx xxxxxxx xxxxxxxxx xxxx xxxxx xxxxxxxxx xx xxxxxxxx. Xxxx xxxx xxxxxx x xxxxxx, xx xxxxxxxx x xxxx, xx xxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxxxxxx x xxxxxxxxxxx x xx xxxxxx xxxxxx x krmivech xx xxxxxx xxxx x xxxxxxxxxxx, xxxx zapotřebí xxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxx. |
(5) |
Xxxxxxxx xxxxxxxxx na xxxxxxxxxxxx xx xxxxxxx xx xxx xxxxxxxxxx xxxx xx nutné. Úřad xxxx ověřil xxxxxx x metodě xxxxxxx xxxxxxxxxxx látek x xxxxxxxx, které xxxxxxxxxx xxxxxxxxxx laboratoř zřízená xxxxxxxxx (ES) č. 1831/2003. |
(6) |
X zájmu lepší xxxxxxxx xx měly xxx stanoveny xxxxxx xxxxxxxx x xxxxxxx. Xxx xxxxxxx xxxxx xx xxx xxx xx xxxxxxx xxxxxxxxx xxxxx uveden xxxxxxxxxx xxxxx. Pokud xx xxxxxxxxxx obsah překročen, xxxx xx xxx xx xxxxxxx xxxxxxx x x xxxxxxxx xxxxxxx směsí x xxxxxxx xxxxxxx uvedeny xxxxxx xxxxxxxxx. |
(7) |
Xxxxxxxxx dotčených xxxxx xxxxxxxxx, xx xxxxxxxx xxx xxxxxxxx xxxxxxxxx x xxxxxx 5 xxxxxxxx (XX) x. 1831/2003 xxxx xxxxxxx xxx xxxxxxx x xxxxxx. Xxxxx xx xxxxxxxxx uvedených xxxxxxxxxxx xxxxx mělo xxx xxxxxxxx podle xxxxxxx xxxxxx xxxxxxxx. |
(8) |
Xxxxxxxx x xxxx, že xxxxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxx změn x xxxxxxxxxx xxx xxxxxxxx xxxxxxxxx xxxxx, xx vhodné stanovit xxxxxxxxx xxxxxx, xxxxx xx xxxxxxxxxxx stranám xxxxxxxx připravit xx xx xxxxxx nových xxxxxxxxx xxxxxxxxxxxxx x xxxxxxxx. |
(9) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx jsou x xxxxxxx xx stanoviskem Xxxxxxx xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x xxxxxx, |
XXXXXXX XXXX XXXXXXXX:
Xxxxxx 1
Povolení
Látky uvedené x xxxxxxx, xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxx xxxxx „senzorické xxxxxxxxx xxxxx“ a xxxxxxx xxxxxxx „xxxxxxxxxxx látky“, xx povolují xxxx xxxxxxxxx xxxxx xx xxxxxx xxxxxx xxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxxxx.
Xxxxxx 2
Xxxxxxxxx xxxxxxxx
1. Xxxxx xxxxxxx x xxxxxxx x xxxxxxx xxxxxxxxxx xxxx xxxxx, xxxxxxxx x označené před 19. xxxxxxxxx 2019 x xxxxxxx s xxxxxxxx xxxxxxxx xxxx 19. xxxxxxxxx 2019, xxxxx xxx uváděny xx trh x xxxxxxxxx xx do 19. června 2020.
2. Xxxxx xxxxx a xxxxx xxxxxxxx xxxxxxxxxx látky xxxxxxx v příloze, xxxxxxxx a označené xxxx 19. prosincem 2021 x souladu x xxxxxxxx xxxxxxxx xxxx 19. prosincem 2019, mohou být xxxxxxx xx xxx x xxxxxxxxx xx xx xxxxxxxxx xxxxxxxxxxx xxxxx, jestliže xxxx xxxxxx pro xxxxx x psy.
Xxxxxx 3
Xxxxx v xxxxxxxx
Xxxx xxxxxxxx xxxxxxxx x platnost xxxxxxxx xxxx xx vyhlášení x Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.
Xxxx xxxxxxxx je xxxxxxx v xxxxx xxxxxxx x xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.
V Xxxxxxx xxx 26. xxxxxxxxx 2019.
Xx Komisi
xxxxxxxx
Xxxx-Xxxxxx JUNCKER
(1)&xxxx;&xxxx;Xx. xxxx. L 268, 18.10.2003, x. 29.
(2)&xxxx;&xxxx;Xxxxxxxx Xxxx 70/524/EHS xx dne 23. xxxxxxxxx 1970 x xxxxxxxxxxx xxxxxxx v xxxxxxxx (Xx. xxxx. X 270, 14.12.1970, x. 1).
(3) EFSA Xxxxxxx 2019;17(3):5649.
(4)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x. 429/2008 xx xxx 25. dubna 2008 x xxxxxxxxxxx xxxxxxxxxx x nařízení Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1831/2003, pokud jde x xxxxxxxxxxx x xxxxxxxx xxxxxxx a xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxx (Xx. xxxx. X 133, 22.5.2008, s. 1).
PŘÍLOHA
Identifikační číslo xxxxxxxxx xxxxx |
Xxxxx xxxxxxxx xxxxxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxx, xxxxxxxx xxxxxx, xxxxx, xxxxxxxxxx xxxxxx |
Xxxx xxxx xxxxxxxxx zvířat |
Maximální xxxxx |
Xxxxxxxxx xxxxx |
Xxxxxxxxx xxxxx |
Xxxx xxxxxxxxxx |
Xxxxx xxxxxxxxx xxxxxxxx |
||||||||||
xx xxxxxx látky/kg xxxxxxxxxxx xxxxxx x obsahu xxxxxxxx 12 % |
|||||||||||||||||||
Xxxxxxxxx: xxxxxxxxxx doplňkové xxxxx. Xxxxxxx skupina: xxxxxxxxxxx xxxxx |
|||||||||||||||||||
2x5169 |
– |
12-xxxxxxxxxxxxxxxx |
Xxxxxxx doplňkové xxxxx: 12-xxxxxxxxxxxxxxxx Xxxxxxxxxxxxxxx xxxxxx xxxxx: 12-xxxxxxxxxxxxxxxx Xxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxx: minimálně 97 % Xxxxxxxx xxxxxx: X14X28X Xxxxx XXX: 75853-49-5 FLAVIS: 05.169 Analytická xxxxxx (1) : Xxx xxxxxxxxx 12-xxxxxxxxxxxxxxxxx x xxxxxxxxx xxxxx x ve xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx spektrometrie x xxxxxxxxx time xxxxxxx (XX/XX/XXX). |
xxxxx x xxx |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x5057 |
– |
xxxx-2(xxxxx),4(xxxxx)-xxxxxx |
Xxxxxxx xxxxxxxxx xxxxx: xxxx-2(xxxxx),4(xxxxx)-xxxxxx Xxxxxxxxxxxxxxx xxxxxx xxxxx: xxxx-2(xxxxx),4(xxxxx)-xxxxxx Xxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxx: xxxxxxxxx 97 % Xxxxxxxx xxxxxx: C6H8O Číslo XXX: 142-83-6 XXXXXX: 05.057 Xxxxxxxxxx metoda &xxxx;(1) : Pro xxxxxxxxx xxxx-2(xxxxx),4(xxxxx)-xxxxxxx x xxxxxxxxx látce x xx xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx xxxxxxxxxxxxx x xxxxxxxxx xxxx locking (XX/XX/XXX). |
xxxxx x xxx |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x5078 |
– |
xxxxxx-2-xxxx |
Xxxxxxx xxxxxxxxx xxxxx: xxxxxx-2-xxxx Xxxxxxxxxxxxxxx xxxxxx xxxxx: xxxxxx-2-xxxx Xxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxx: xxxxxxxxx 92 % Xxxxxxxx xxxxxx: X13X24 X Xxxxx CAS: 7774-82-5 XXXXXX: 05.078 Analytická metoda &xxxx;(1) : Pro xxxxxxxxx tridec-2-enalu x xxxxxxxxx xxxxx x xx xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx spektrometrie x xxxxxxxxx xxxx xxxxxxx (XX/XX/XXX). |
xxxxx a psi |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x13084 |
2-xxxxx-4-xxxxxxx-5-xxxxxx-3 (2X)-xxxxxxx |
Xxxxxxx xxxxxxxxx látky: 2-ethyl-4-hydroxy-5-methyl-3 (2X)-xxxxxxx Xxxxxxxxxxxxxxx xxxxxx xxxxx: 2-xxxxx-4-xxxxxxx-5-xxxxxx-3 (2X)-xxxxxxx Xxxxxxx xxxxxxxxx syntézou Čistota: minimálně 97 % Xxxxxxxx vzorec: X7X10X3 Xxxxx XXX: 27538-09-6 FLAVIS: 13.084 Xxxxxxxxxx xxxxxx &xxxx;(1) : Xxx xxxxxxxxx 2-xxxxx-4-xxxxxxx-5-xxxxxx-3 (2X)-xxxxxxxx x doplňkové xxxxx x xx xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx spektrometrie x xxxxxxxxx xxxx xxxxxxx (XX/XX/XXX). |
xxxxx a xxx |
|
19.12.2029 |
||||||||||||||
2b12005 |
– |
fenylmethanthiol |
Složení xxxxxxxxx látky: fenylmethanthiol Charakteristika účinné xxxxx: xxxxxxxxxxxxxxxx Xxxxxxx chemickou xxxxxxxx Xxxxxxx: xxxxxxxxx 99 % Xxxxxxxx xxxxxx: X7X8X Xxxxx XXX: 100-53-8 XXXXXX: 12.005 Xxxxxxxxxx xxxxxx &xxxx;(1) : Xxx xxxxxxxxx xxxxxxxxxxxxxxxxx x xxxxxxxxx xxxxx x xx xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx xxxxxxxxxxxxx x xxxxxxxxx xxxx locking (XX/XX/XXX). |
xxxxx x psi |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x12077 |
– |
xxxxxx(xxxxxx)xxxxxx |
Xxxxxxx doplňkové xxxxx: xxxxxx(xxxxxx)xxxxxx Xxxxxxxxxxxxxxx xxxxxx xxxxx: xxxxxx(xxxxxx)xxxxxx Xxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxx: minimálně 99 % Xxxxxxxx xxxxxx: C8H10S Číslo XXX: 766-92-7 FLAVIS: 12.077 Xxxxxxxxxx xxxxxx &xxxx;(1) : Pro xxxxxxxxx xxxxxx(xxxxxx)xxxxxxx v xxxxxxxxx xxxxx x xx zchutňujících premixech: plynová xxxxxxxxxxxxxx/xxxxxxxxxx xxxxxxxxxxxxx s xxxxxxxxx xxxx locking (XX/XX/XXX). |
xxxxx a xxx |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x4019 |
– |
2,5-xxxxxxxxxxxxx |
Xxxxxxx xxxxxxxxx xxxxx: 2,5-xxxxxxxxxxxxx Xxxxxxxxxxxxxxx účinné látky: 2,5-dimethylfenol Vyroben xxxxxxxxx xxxxxxxx Xxxxxxx: minimálně 99 % Chemický xxxxxx: X8X10X Xxxxx XXX: 95-87-4 XXXXXX: 04.019 Xxxxxxxxxx xxxxxx &xxxx;(1) : Xxx xxxxxxxxx 2,5-xxxxxxxxxxxxxx x xxxxxxxxx xxxxx a xx xxxxxxxxxxxxx xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx spektrometrie x xxxxxxxxx time locking (XX/XX/XXX). |
xxxxx x xxx |
– |
– |
– |
|
19.12.2029 |
||||||||||
2x15096 |
– |
2-xxxxxxxxxxxxx |
Xxxxxxx doplňkové xxxxx: 2-xxxxxxxxxxxxx Xxxxxxxxxxxxxxx účinné xxxxx: 2-xxxxxxxxxxxxx Xxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxx: xxxxxxxxx 98 % Xxxxxxxx xxxxxx: X9X14X Xxxxx CAS: 4861-58-9 XXXXXX: 15.096 Xxxxxxxxxx xxxxxx &xxxx;(1) : Xxx xxxxxxxxx 2-xxxxxxxxxxxxxx x xxxxxxxxx látce a xx zchutňujících xxxxxxxxx: xxxxxxx xxxxxxxxxxxxxx/xxxxxxxxxx spektrometrie s xxxxxxxxx xxxx xxxxxxx (XX/XX/XXX). |
xxxxx x psi |
– |
– |
– |
|
19.12.2029 |
(1)&xxxx;&xxxx;Xxxxxxxx informace x analytických xxxxxxxx xxx xxxxxx na xxxxxxxxxxx xxxxxxx referenční xxxxxxxxxx: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports